Latest research on COPDNew research on asthma

Latest research on COPD:

A study published in the American Journal of Respiratory and Critical Care Medicine found that patients with COPD who received a combination of inhaled corticosteroids and long-acting beta-agonists had a lower risk of hospitalization and death compared to those who received only one of the medications.
Another study published in the journal Chest found that patients with COPD who received pulmonary rehabilitation had a lower risk of hospitalization and death compared to those who did not receive rehabilitation.
A study published in the European Respiratory Journal found that air pollution exposure is associated with increased risk of COPD exacerbations.
A study published in the Journal of the American Medical Association found that patients with COPD who received a combination of inhaled corticosteroids, long-acting beta-agonists, and muscarinic antagonists had a lower risk of exacerbations and hospitalizations compared to those who received only one or two of the medications.

Latest research on asthma:

A study published in the New England Journal of Medicine found that patients with severe asthma who received biologic therapy had a lower risk of asthma exacerbations and improved lung function compared to those who received placebo.
Another study published in the journal Respiratory Medicine found that patients with asthma who received a combination of inhaled corticosteroids and long-acting beta-agonists had a lower risk of exacerbations and improved lung function compared to those who received only one of the medications.
A study published in the Journal of Allergy and Clinical Immunology found that patients with asthma who received allergen immunotherapy had a lower risk of asthma exacerbations and improved lung function compared to those who did not receive immunotherapy.
A study published in the Journal of Asthma found that patients with asthma who received mindfulness-based stress reduction therapy had improved quality of life and reduced asthma symptoms compared to those who did not receive the therapy.